Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Program Death-1 Engagement Upon TCR Activation Has Distinct Effects on Costimulation and Cytokine-Driven Proliferation: Attenuation of ICOS, IL-4, and IL-21, But Not CD28, IL-7, and IL-15 Responses

Frann Bennett, Deborah Luxenberg, Vincent Ling, I-Ming Wang, Kim Marquette, David Lowe, Nighat Khan, Geertruida Veldman, Kenneth A. Jacobs, Viia E. Valge-Archer, Mary Collins and Beatriz M. Carreno
J Immunol January 15, 2003, 170 (2) 711-718; DOI: https://doi.org/10.4049/jimmunol.170.2.711
Frann Bennett
†Wyeth Research, Cambridge, MA 02140
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Luxenberg
†Wyeth Research, Cambridge, MA 02140
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Ling
†Wyeth Research, Cambridge, MA 02140
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I-Ming Wang
†Wyeth Research, Cambridge, MA 02140
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim Marquette
†Wyeth Research, Cambridge, MA 02140
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Lowe
*Cambridge Antibody Technology, Abington, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nighat Khan
*Cambridge Antibody Technology, Abington, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geertruida Veldman
†Wyeth Research, Cambridge, MA 02140
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth A. Jacobs
†Wyeth Research, Cambridge, MA 02140
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viia E. Valge-Archer
*Cambridge Antibody Technology, Abington, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Collins
†Wyeth Research, Cambridge, MA 02140
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatriz M. Carreno
†Wyeth Research, Cambridge, MA 02140
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    PD-1 and PD-L are expressed by human CD4+ T cells upon activation. A, CD4+ T cells were activated with protein-coated microspheres as described in Materials and Methods. At the indicated times, cells were harvested, washed once, and stained with either anti-huPD-1, anti-huPD-L1, anti-CD25, or anti-CD69 Abs. Control Ab isotype (thin line) was included for each staining. Cell populations were analyzed by flow cytometry using a FACScan. A representative experiment is shown (n = 3). B, RNA was prepared from unstimulated or 72 h anti-CD3 activated cells. PCR analysis was performed as described in Materials and Methods. Control indicates PCR performed in the absence of RNA. All RNA samples were also assessed for expression of GAPDH, a housekeeping gene.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Anti-PD-1 Ab can deliver a negative signal to human CD4+ T cells. A, Purified CD4+ T cells (105 cells/well) were activated with microspheres coated with a fixed concentration of anti-CD3 Ab (1 μg/107 microspheres) and increasing concentrations of PD-L1.Fc or PD1–17 Ab. Activation in the absence of PD-1 engagement was determined using microspheres containing anti-CD3 Ab (1 μg) and murine IgG (4 μg/107 microspheres). For comparison purposes, values are represented as the percentage of anti-CD3 Ab response, where 100% represent cpm obtained when cells were activated with anti-CD3/murine IgG-coated microspheres. A representative experiment is shown (n = 3). B, Cells (105 cells/well) were activated with anti-CD3, anti-CD3/PD-L1.Fc, and anti-CD3/anti-PD1–17 microspheres in the presence of increasing concentrations of soluble anti-CD28 Ab. Two sets of anti-CD3 microspheres are shown, one for each of the corresponding isotypes (muIgG2a for PD-L1.Fc and huIgG1 for anti-PD1–17). Proliferation was measured at 72 h. Similar results were obtained with multiple donors (n = 3). C, Cells (105 cells/well) were activated with anti-CD3, anti-CD3/PD-L1.Fc (CIS), and anti-CD3 + PD-L1.Fc (TRANS) microspheres. CIS microspheres contained both anti-CD3 and PD-L1.Fc on the same bead, TRANS microspheres consist of two beads, one containing anti-CD3, and one containing PD-L1.Fc. To maintain equal bead to cell ratios in CIS and TRANS conditions, microspheres coated with muIgG control were added to CIS cultures. In all cases, control murine Ig was added to achieve a total protein concentration of 5 μg/107 microspheres. Proliferation was measured at 72 h. Similar results were obtained with multiple donors (n = 6).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Soluble anti-PD-1 Abs enhance T-T cell responses. CD4+ T cell were preactivated for 72 h with anti-CD3/anti-CD28-coated microspheres, harvested, and restimulated with increasing concentrations of PHA in the presence of IL-2 (10 ng/ml) and anti-PD-1 Ab (20 μg/ml) (A) or increasing concentrations of anti-PD-1 Ab in the presence of 0.1% PHA + 10 ng/ml IL-2 (B). Proliferation was measured at 72 h (n = 3).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    ICOS costimulation can be prevented by PD-1 engagement. A, CD4+ T cells were activated with microspheres coated with anti-CD3/control Ig (1 μg/4 μg/107 microspheres), anti-CD3/PD-L1.Fc/control Ig, anti-CD3/ICOS-L.Fc/control Ig, anti-CD3/B7-2.Fc/control Ig, anti-CD3/PD-L1.Fc/ICOS-L.Fc, or anti-CD3/PD-L1.Fc/B7-2.Fc (1 μg/2 μg/2 μg/107 microspheres). Microsphere composition is indicated in the chart below x-axis. Proliferation was measured at 72 h. Statistical analysis indicated that CD3/PD-L (p = 0.0386), CD3/ICOS-L (p = 0.0393), CD3/B7 (p = 0.0019), and CD3/B7/PD-L (p = 0.0099) responses differed significantly from CD3 responses; in contrast, no statistical significance was observed between CD3/ICOS-L/PD-L (p = 0.9836) and CD3 responses. B, Supernatants were harvested at 24 h and IL-2 production analyzed by ELISA (sensitivity 20 pg/ml). Inset, IL-2 transcript relative expression under stimulation conditions. Values are normalized for GAPDH expression (n = 2). C, CD4+ T cells were activated as in A in the presence of a neutralizing murine anti-human IL-2 Ab (20 μg/ml) or control murine IgG. Microsphere composition and presence of neutralizing IL-2 Ab is indicated in the figure below the x-axis. Statistical analysis indicated that CD3/PD-L (p = 0.0209), CD3/ICOS-L (p = 0.0045) responses differed significantly from CD3 responses; no statistical significance was observed between CD3/ICOS-L/PD-L (p = 0.0759) and CD3 responses. CD3/ICOS-L/PD-L plus anti-IL-2 Ab (p = 0.0419) responses differed significantly from CD3/ICOS-L/PD-L responses. Proliferation was measured at 72 h. Summaries of results obtained with four to eight donors are shown. Horizontal lines represent mean value for each condition.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    IL-2, IL-7, and IL-15 but not IL-4 or IL-21 rescue PD-1-mediated inhibition. CD4+ T cells were activated with microspheres coated with anti-CD3 (•) or anti-CD3/PD-L1.Fc (○) in the presence of increasing concentrations of IL-2 (A), IL-7 (B), IL-15 (C), IL-4 (D), and IL-21 (E). Proliferation was measured at 72 h. A representative experiment is shown (n = 6).

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    IL-21 activation of primary human CD4+ T cells does not result in STAT5 phosphorylation. CD4+ T cells were activated with anti-CD3 Ab-coated microspheres for 5 and 24 h followed by addition of 100 ng/ml IL-2 or IL-21 for 15 min. Cell lysates were immunoblotted and analyzed for total and phosphorylated STAT1 (A), STAT3 (B), and STAT5 (C) as described in Materials and Methods (n = 3).

Tables

  • Figures
    • View popup
    Table I.

    Treatment of T cells with IL-2, IL-7, and IL-15 but not IL-4 and IL-21, leads to up-regulation of IL-2Rα chaina

    MediaIL-2IL-4IL-7IL-15IL-21
    IsotypeAnti-CD25IsotypeAnti-CD25IsotypeAnti-CD25IsotypeAnti-CD25IsotypeAnti-CD25IsotypeAnti-CD25
    Anti-CD33.4496.755.35 736.86 3.594.125.31 622.07 4.69 488.4 4.16100.12
    Anti-CD3/PD-L1.Fc3.1246.384.49 307.03 4.0551.414.18 246.99 4.46 272 4.3451.42
    • a CD4+ T cells were activated with anti-CD3 Ab-coated microspheres in the presence of optimal concentrations of the indicated cytokines. At 72 h, cells were harvested and stained for IL-2Rα (CD25) expression as described in Materials and Methods (n = 2). Mean fluorescence values are shown, bold numbers indicate increases 4-fold above media control.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 170 (2)
The Journal of Immunology
Vol. 170, Issue 2
15 Jan 2003
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Program Death-1 Engagement Upon TCR Activation Has Distinct Effects on Costimulation and Cytokine-Driven Proliferation: Attenuation of ICOS, IL-4, and IL-21, But Not CD28, IL-7, and IL-15 Responses
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Program Death-1 Engagement Upon TCR Activation Has Distinct Effects on Costimulation and Cytokine-Driven Proliferation: Attenuation of ICOS, IL-4, and IL-21, But Not CD28, IL-7, and IL-15 Responses
Frann Bennett, Deborah Luxenberg, Vincent Ling, I-Ming Wang, Kim Marquette, David Lowe, Nighat Khan, Geertruida Veldman, Kenneth A. Jacobs, Viia E. Valge-Archer, Mary Collins, Beatriz M. Carreno
The Journal of Immunology January 15, 2003, 170 (2) 711-718; DOI: 10.4049/jimmunol.170.2.711

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Program Death-1 Engagement Upon TCR Activation Has Distinct Effects on Costimulation and Cytokine-Driven Proliferation: Attenuation of ICOS, IL-4, and IL-21, But Not CD28, IL-7, and IL-15 Responses
Frann Bennett, Deborah Luxenberg, Vincent Ling, I-Ming Wang, Kim Marquette, David Lowe, Nighat Khan, Geertruida Veldman, Kenneth A. Jacobs, Viia E. Valge-Archer, Mary Collins, Beatriz M. Carreno
The Journal of Immunology January 15, 2003, 170 (2) 711-718; DOI: 10.4049/jimmunol.170.2.711
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606